Testing Page

Home/Testing Page
Testing Page2017-05-12T05:09:15-05:00

WHO WE ARE

LifeScienceRisk specializes in core liability consisting of Product Liability, Errors and Omissions Liability and General Liability for Life Science companies engaged in the discovery, development, manufacturing, distribution and promotion of products including pharmaceuticals, medical devices, biotechnology, dietary supplements as well as compounds and devices in human clinical trials. We offer a comprehensive suite of coverages which are distributed by specialist retail and wholesale brokers who value a facility that both understands their clients’ needs and strives to provide meaningful and stable financial protection. We offer expertise to firms from innovative start-up ventures to large sophisticated companies with worldwide operations. Leading the LifeScienceRisk operation is Mark D. Wood, a prominent figure in the Life Science insurance community, with over 35 years of experience in specialty commercial insurance, loss control and underwriting in the Healthcare and Life Science segments.

OUR MISSION

LifeScienceRisk is committed to providing outstanding specialty insurance solutions and quality services to protect and partner with Life Science industry companies as they research, innovate and develop products, treatments and cures to improve the human condition around the globe.

[one_half last=”no” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” hover_type=”none” link=”” border_position=”all” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ animation_offset=”” class=”” id=””]
PHARMACEUTICALS
Brand Pharmaceuticals
Firms that innovate and manufacture prescription drugs with the authorization of the FDA under the New Drug Application (NDA) process.
Generic Pharmaceuticals
Firms that produce bioequivalent replications of brand-name drugs in terms of dosage, safety, strength, route of administration, quality, performance and intended use with the authorization of the FDA under the Abbreviated New Drug Application (ANDA) process.
ACTIVE PHARMACEUTICAL INGREDIENTS
Substances used in the manufacturing of final drug products that provide a direct therapeutic effect in the management, treatment or prevention of disease.
COMPOUNDING OPERATIONS
The combining of drugs for specific patients with needs that can’t be met by commercially available medicines.
MEDICAL DEVICES
Appliances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or other conditions with the authorization of the FDA under the Investigational Device Exemption (IDE) or premarket notification (510k) process. Medical devices range from non-invasive to implantable products.
[/one_half] [one_half last=”no” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” hover_type=”none” link=”” border_position=”all” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ animation_offset=”” class=”” id=””]
BIOLOGICS
Medicinal preparations made from living organisms that govern the rhythmic occurrence of certain biochemical, physiologic, and behavioral phenomena of the human genome with the authorization of the FDA under the Biologics License Application (BLA).
VACCINES
Substances prepared from the causative agent of a disease or a synthetic substitute that are used to stimulate the production of antibodies and provide immunity against one or several diseases with the authorization of the FDA under the BLA.
DIETARY SUPPLEMENTS
Includes vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. The FDA regulates the dietary supplement industry under the 1994 Dietary Supplement Health and Education Act and the New Dietary Ingredient (NDI) notification process.
DRUG DISCOVERY & DEVELOPMENT
The process by which new candidate medications are discovered and studied prior to human testing.
HUMAN CLINICAL TRIALS
Research studies with human volunteer participants to evaluate one or more health-related interventions to determine efficacy of a novel compound or device. Human Clinical Trials are overseen by the FDA Center for Drug Evaluation and Research through the review and approval of the study protocols and informed consent documents.
[/one_half]
Legal  |  Privacy

Life Science Risk is a series of RSG Underwriting Managers, LLC. RSG Underwriting Managers is a Delaware series limited liability company and a subsidiary of Ryan Specialty Group, LLC, specializing in underwriting management and other services for insurance products distributed through agents and brokers. In California: RSG Insurance Services, LLC License # 0E50879 ©2021 Ryan Specialty Group, LLC

LifeScience International is a tradename of RSG Underwriting Managers Europe Limited. Registered office is 30 St. Mary Axe, 13th Floor, London, EC3A 8BF. Company number 07164987. RSG Underwriting Managers Europe Limited is authorised and regulated by the Financial Conduct Authority. LifeScience EEA is a trading name of Ryan Specialty Group Sweden AB. Registered office is Ingmar Bergmansgata 2, 114 34 Stockholm, Sweden. Org nr 556741-6572. Ryan Specialty Group Sweden AB is authorized by the Swedish Financial Services Authority.

RSG Underwriting Managers, LLC, RSG Underwriting Managers Europe Limited and Ryan Specialty Group Sweden AB are subsidiaries of Ryan Specialty Group, LLC.